Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Feb 27, 2007

Genedata Joins European Systems Biology Initiative BaSysBio

  • Swiss-based computational biology provider Genedata is participating in BaSysBio, an integrated systems biology project involving 15 research organizations from nine European countries.

    BaSysBio (Bacillus Systems Biology) will study the global regulation of gene transcription in the model bacterium Bacillus subtilis. This bacterium has significant economic potential as a producer of enzymes and metabolites and is used in a wide range of industries. Bacillus anthracis and Staphylococcus aureus are objects of research as well.

    BaSysBio’s goal is to provide new insight into the fundamental principles that control cellular processes. Subsequently, the initiative will contribute to the identification of new biomarkers and innovative therapeutic targets for antibacterial drugs.

    Genedata Phylosopher has been chosen as the central management and infrastructure solution for sharing and interpreting the experimental data generated within BaSysBio. The project will adapt an array of high-throughput genomics technologies, including transcriptomics, proteomics, metabolomics, fluxomics, and cell reporter assays.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »